Challenges of evaluating the cardiac effects of anticancer agents
Clin Cancer Res
.
2006 Jul 1;12(13):3871-4.
doi: 10.1158/1078-0432.CCR-06-1017.
Authors
Susan E Bates
,
Douglas R Rosing
,
Tito Fojo
,
Richard L Piekarz
PMID:
16818679
DOI:
10.1158/1078-0432.CCR-06-1017
No abstract available
Publication types
Comment
Editorial
Review
MeSH terms
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Heart / drug effects*
Heart Diseases / chemically induced*
Humans
Neoplasms / drug therapy*
Risk Factors
Substances
Antineoplastic Agents